NEW DRUG APPROVALS
TODAY'S HEADLINES
AbbVie's new Viekira XR for chronic hepatitis C virus is different than other drugs on the market. Here's how |
|
Merck's Wall Street value is climbing after its cancer drug pembrolizumab (Keytruda) received yet another approval from FDA. Read more
|
CONTINUING PHARMACY EDUCATION
This month's CE activity, "Interventions to improve quality of life for patients with psoriasis and psoriatic arthritis," is open for pharmacists and pharmacy technicians.
The goal of this activity is to educate pharmacists and pharmacy technicians about pharmacist intervention in improving the quality of life for patients with psoriasis and psoriatic arthritis.
Pharmacists and pharmacy technicians can earn up to 2 hours of CPE credit for completing this knowledge-based activity from the University of Connecticut School of Pharmacy and Drug Topics. More
|
EDITOR'S PICK
FDA recently approved Adlyxin (Sanofi, NOT Sanofi Aventis), a once-daily mealtime GLP-1 receptor agonist injection for type 2 diabetes. The drug's big competitors
|
|
|
